AU2002351214B2 - Methods and reagents for diagnosis and treatment of diabetes - Google Patents

Methods and reagents for diagnosis and treatment of diabetes Download PDF

Info

Publication number
AU2002351214B2
AU2002351214B2 AU2002351214A AU2002351214A AU2002351214B2 AU 2002351214 B2 AU2002351214 B2 AU 2002351214B2 AU 2002351214 A AU2002351214 A AU 2002351214A AU 2002351214 A AU2002351214 A AU 2002351214A AU 2002351214 B2 AU2002351214 B2 AU 2002351214B2
Authority
AU
Australia
Prior art keywords
seq
polypeptide
archipelin
cell
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002351214A
Other languages
English (en)
Other versions
AU2002351214A1 (en
Inventor
John E. Blume
Jeffrey D. Johnson
John F. Palma
Yun-Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CymaBay Therapeutics Inc
Original Assignee
Metabolex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolex Inc filed Critical Metabolex Inc
Publication of AU2002351214A1 publication Critical patent/AU2002351214A1/en
Application granted granted Critical
Publication of AU2002351214B2 publication Critical patent/AU2002351214B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002351214A 2001-12-03 2002-12-02 Methods and reagents for diagnosis and treatment of diabetes Ceased AU2002351214B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33663301P 2001-12-03 2001-12-03
US60/336,633 2001-12-03
PCT/US2002/038556 WO2003047421A2 (en) 2001-12-03 2002-12-02 Methods and reagents for diagnosis and treatment of diabetes

Publications (2)

Publication Number Publication Date
AU2002351214A1 AU2002351214A1 (en) 2003-06-17
AU2002351214B2 true AU2002351214B2 (en) 2008-09-11

Family

ID=23316971

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351214A Ceased AU2002351214B2 (en) 2001-12-03 2002-12-02 Methods and reagents for diagnosis and treatment of diabetes

Country Status (6)

Country Link
US (2) US7144985B2 (enExample)
EP (1) EP1461351A4 (enExample)
JP (1) JP2006500002A (enExample)
AU (1) AU2002351214B2 (enExample)
CA (1) CA2468991A1 (enExample)
WO (1) WO2003047421A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7054758B2 (en) 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
RU2305109C2 (ru) * 2001-03-15 2007-08-27 Рисерч Дивелопмент Фаундейшн Урокортин iii, его аналог (варианты) и фармацевтическая композиция
US20090136465A1 (en) 2007-09-28 2009-05-28 Intrexon Corporation Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
BRPI0921640A2 (pt) * 2008-11-04 2019-09-24 Janssen Pharmaceutica Nv agonistas peptídicos do crhr2 e usos do mesmo
EP2584041A1 (en) * 2011-10-21 2013-04-24 Industrial Cooperation Foundation Chonbuk National University Composition for preventing or treating diabetes comprising nad glycohydrolase inhibitor as active ingredient

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002306853B2 (en) * 2001-03-15 2006-07-06 Research Development Foundation Urocortin-III and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002306853B2 (en) * 2001-03-15 2006-07-06 Research Development Foundation Urocortin-III and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Hsu et al. Nature Medicine 2001, 7(5), 605-611 *
Lewis et al. PNAS 2001, 98(13), 7570-7575 *

Also Published As

Publication number Publication date
AU2002351214A1 (en) 2003-06-17
JP2006500002A (ja) 2006-01-05
WO2003047421A2 (en) 2003-06-12
US20070055050A1 (en) 2007-03-08
US20030202976A1 (en) 2003-10-30
US7144985B2 (en) 2006-12-05
EP1461351A2 (en) 2004-09-29
WO2003047421A3 (en) 2003-10-30
CA2468991A1 (en) 2003-06-12
EP1461351A4 (en) 2006-09-13
US7294698B2 (en) 2007-11-13

Similar Documents

Publication Publication Date Title
US20080064857A1 (en) Methods and Reagents for Diagnosis and Treatment of Diabetes
AU2004289247A1 (en) Compositions and methods for diagnosing and treating mental disorders
US20070122802A1 (en) Methods of diagnosing and treating diabetes and insulin resistance
US7294698B2 (en) Methods and reagents for diagnosis and treatment of diabetes
US20060228706A1 (en) Methods of diagnosing and treating diabetes and insulin resistance
US7053180B2 (en) Isolated islet beta-cell two-pore domain potassium channel
US20060292563A1 (en) Methods of diagnosing & treating diabetes and insulin resistance
US20060234292A1 (en) Methods of diagnosing and treating diabetes and insulin resistance
US20060210974A1 (en) Compositions and methods for preventing, treating and diagnosing diabetes
US20080318312A1 (en) Pancreatic islet transcription factor and uses thereof
US20060074018A1 (en) Methods of diagnosing & treating diabetes and insulin resistance
US7341832B2 (en) Genes involved in neuropsychiatric disorders
WO2005124359A2 (en) Methods of diagnosing and treating diabetes and insulin resistance
US20050208516A1 (en) Methods and reagents for diagnosis and treatment of diabetes
US20080118434A1 (en) Genes Commonly Regulated by Different Classes of Antidepressants

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired